New injection offers hope for blood cancer patients who can't use standard treatments
NCT ID NCT04182100
Summary
This study tested whether P1101 injections could help adults with polycythemia vera, a rare blood cancer, when standard treatments don't work well. Twenty-nine Japanese patients received injections every two weeks for a year to see if the treatment could control their blood counts without needing regular blood removal. Researchers measured whether patients could maintain healthy blood levels and avoid complications like blood clots.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA (PV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ehime University Hospital
Toon-shi, Ehime, 791-0295, Japan
-
Juntendo University Hospital
Bunkyo-ku, Tokyo, 113-8431, Japan
-
Keio University Hospital
Shinjuku-ku, Tokyo, 160-8582, Japan
-
Mie University Hospital
Tsu, Mie-ken, Japan
-
NTT Medical Center Tokyo
Shinagawa-ku, Tokyo, 141-8625, Japan
-
Osaka University Hospital
Suita-shi, Osaka, 565-0871, Japan
-
Tokyo Medical University Hospital
Shinjuku-ku, Tokyo, 160-0023, Japan
-
University of Yamanashi Hospital
Chuo-shi, Yamanashi, 409-3898, Japan
Conditions
Explore the condition pages connected to this study.